EFDID: 140315EFD: View Filing

Issuer: Kalytera Therapeutics, Inc. (0001639643) - D

Accession: 0001639643-15-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001639643
  • Entity Name:
    Kalytera Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2014)
  • Address:
    245 33RD STREET
    HERMOSA BEACH, CA 90254
  • Persons:
    Related Persons 2
    Seth Yakatan
    Executive Officer, Director
    David Stefansky
    Director
EDGAR: Offering Information
  • Accession Date:
    04/23/2015
  • First Sale Date:
    12/23/2014
  • Offering Amount:
    $100,000
  • Amount Sold:
    $100,000
  • Exemptions:
    4a5, Rule 506 , Rule 505
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Kalytera Therapeutics, Inc./s/ Seth YakatanSeth YakatanChief Executive Officer2015-04-21